Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications

Cell Commun Signal. 2023 Dec 18;21(1):359. doi: 10.1186/s12964-023-01357-0.

Abstract

RNA methylation modification plays a crucial role as an epigenetic regulator in the oncogenesis of hepatocellular carcinoma (HCC). Numerous studies have investigated the molecular mechanisms underlying the methylation of protein-coding RNAs in the progression of HCC. Beyond their impact on mRNA, methylation modifications also influence the biological functions of non-coding RNAs (ncRNAs). Here, we present an advanced and comprehensive overview of the interplay between methylation modifications and ncRNAs in HCC, with a specific focus on their potential implications for the tumor immune microenvironment. Moreover, we summarize promising therapeutic targets for HCC based on methylation-related proteins. In the future, a more profound investigation is warranted to elucidate the effects of ncRNA methylation modifications on HCC pathogenesis and devise valuable intervention strategies. Video Abstract.

Keywords: HCC; m1A; m5C; m6A; ncRNA.

Publication types

  • Video-Audio Media
  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Humans
  • Liver Neoplasms* / pathology
  • Methylation
  • RNA / metabolism
  • RNA Methylation
  • RNA, Untranslated / genetics
  • RNA, Untranslated / metabolism
  • Tumor Microenvironment

Substances

  • RNA, Untranslated
  • RNA